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A B S T R A C T   
Fast diagnostic methods can control and prevent the spread of pandemic diseases like coronavirus disease 2019 
(COVID-19) and assist physicians to better manage patients in high workload conditions. Although a laboratory 
test is the current routine diagnostic tool, it is time-consuming, imposing a high cost and requiring a well- 
equipped laboratory for analysis. Computed tomography (CT) has thus far become a fast method to diagnose 
patients with COVID-19. However, the performance of radiologists in diagnosis of COVID-19 was moderate. 
Accordingly, additional investigations are needed to improve the performance in diagnosing COVID-19. In this 
study is suggested a rapid and valid method for COVID-19 diagnosis using an artificial intelligence technique 
based. 1020 CT slices from 108 patients with laboratory proven COVID-19 (the COVID-19 group) and 86 patients 
with other atypical and viral pneumonia diseases (the non-COVID-19 group) were included. Ten well-known 
convolutional neural networks were used to distinguish infection of COVID-19 from non-COVID-19 groups: 
AlexNet, VGG-16, VGG-19, SqueezeNet, GoogleNet, MobileNet-V2, ResNet-18, ResNet-50, ResNet-101, and 
Xception. Among all networks, the best performance was achieved by ResNet-101 and Xception. ResNet-101 
could distinguish COVID-19 from non-COVID-19 cases with an AUC of 0.994 (sensitivity, 100%; specificity, 
99.02%; accuracy, 99.51%). Xception achieved an AUC of 0.994 (sensitivity, 98.04%; specificity, 100%; accu-
racy, 99.02%). However, the performance of the radiologist was moderate with an AUC of 0.873 (sensitivity, 
89.21%; specificity, 83.33%; accuracy, 86.27%). ResNet-101 can be considered as a high sensitivity model to 
characterize and diagnose COVID-19 infections, and can be used as an adjuvant tool in radiology departments.   
1. Introduction 
In December 2019, a new coronavirus disease, termed coronavirus 
disease 2019 (COVID-19), was reported in Wuhan, China [1]. The most 
common symptoms of COVID-19 are fever, dyspnea, cough, myalgia, 
and headache [2]. At the time of the study, no specific drug or treatment 
was available. 
According to the WHO, all COVID-19 diagnoses must be confirmed 
by molecular assays, such as the reverse-transcription polymerase chain 
reaction (RT-PCR) [3]. Besides RT-PCR and, medical imaging, computed 
tomography (CT) has become a vital method to assist in the diagnosis 
and management of patients with COVID-19. The prominent chest CT 
findings of COVID-19 are ground-glass opacity (GGO), multifocal patchy 
consolidation, and a ‘crazy-paving’ pattern with a peripheral distribu-
tion [4–6]. 
The critical role of radiologists is to provide early diagnosis and 
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treatment to distinguish the COVID-19 infection from other conditions, 
which may have similar findings at CT [4,5]. For example, GGO is a 
common finding among other atypical and viral pneumonia diseases 
such as influenza, severe acute respiratory syndrome (SARS), and Mid-
dle East respiratory syndrome (MERS) [5,7]. However, the specificity 
and sensitivity of radiologists in diagnosis of COVID-19 were high and 
moderate, respectively [8]. Hence, further investigations are needed to 
help and improve the radiologist’s performance. In addition, congestion 
of patients, as well as a high workload of radiologists, which can in-
crease fatigue, affect diagnostic performance [9,10]. 
Although for the first time, Lodwick used the term computer-aided 
diagnosis (CAD) in the literature in 1966 [11], serious attempts on 
CAD began in the 1980s [12]. Recently, CAD systems have been an 
inseparable part of a routine clinical practice that assist radiologists in 
the process of diagnosis. CAD systems have advantages over radiolo-
gists. They are reproducible and detect the subtle changes that cannot be 
observed by the visual inspection [13]. The CAD systems have been 
widely used to assist radiologists in detecting lung abnormalities. We 
have included a brief literature review and report the highlights of 
computerized methods in lung disease management. The system pro-
posed by Than et al. using Riesz and Gabor transforms obtained an ac-
curacy of 98.73% in detecting lung disease. The accuracy increased to 
99.53% with the combination of Riesz, Gabor, fractal dimension, grey 
level co-occurrence matrix, and grey level run-length matrix based 
features [14]. Gu et al. indicated that a deep convolutional neural 
network (CNN) could detect lung nodules with a competition perfor-
mance metric of 0.7967. They proposed a density-based spatial clus-
tering of applications with noise (DBSCAN) algorithm to improve the 
detection sensitivity of the network [15]. Also, the CAD system based on 
a 3D skeletonization feature proposed by Zhang et al. can assist radiol-
ogists to differentiate lung nodules from interferential vessels [16]. 
Transforming an image to the time–frequency domain by the optimal 
fractional S-transform (OFrST) method can provide meaningful infor-
mation and features, which can be used to diagnose diseases. This 
method was applied on lung CT images by Sun et al. to detect and 
differentiate nodules from the vessels. They employed the Teager–Kaiser 
energy (TKE) in the time–frequency domain to obtain the energy dis-
tribution and characterize lung nodules with 97.87% sensitivity [17]. 
Sun et al. concluded that the CNN represented higher performance than 
deep belief network (DBN) and stacked denoising autoencoder (SDAE) 
in diagnosing malignant lung nodules with an area under the curve 
(AUC) of 0.899 [18]. Furthermore, CAD systems are a useful tool to 
monitor lung function after transplantation. In this regard, Barbosa et al. 
compared the quantitative CT (qCT), pulmonary function testing (PFT), 
and semi-quantitative image scores (SQS) metrics and found that pul-
monary function testing and qCT metrics demonstrated the highest ac-
curacy for monitoring bi- and unilateral lung transplantation with an 
AUC of 0.771 and 0.817, respectively [19]. The potential of CAD systems 
can go even further and help radiologists to detect lung abnormalities by 
computerized analysis of pulmonary sounds [20] and flow and gas 
concentration of breath [21]. 
In this study, we propose a CAD system based on deep learning to 
classify COVID-19 infection versus other atypical and viral pneumonia 
Fig. 1. CT sample images of patients with 
pneumonia. 
(a): A 28-year-old male with confirmed COVID- 
19 pneumonia. The red arrows indicate ground- 
glass opacity in the right and left lower lobes. 
(b): A 33-year-old female patient with confirmed 
COVID-19 pneumonia. The red and yellow ar-
rows indicate typical mixed ground-glass opac-
ity-consolidation patterns in both lobes, and a 
ground-glass opacity pattern in the peripheral 
right upper lobe, respectively. 
(c): An 81-year-old female patient with H1N1 
influenza. The red arrows indicate infection with 
mixed ground-glass opacity and consolidation 
pattern in both lobes 
(d): A 72-year-old male patient with atypical 
pneumonia. The red arrows indicate ground- 
glass opacity in the right middle lobe.   
Fig. 2. CT sample patch images of patients with COVID-19 (a) and other 
atypical and viral pneumonia diseases (b). 
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diseases. We hypothesized that the deep learning method would help 
radiologists in diagnosing infection related to COVID-19. We used ten 
well-known pre-trained convolutional neural networks (CNN) to di-
agnose infections related to the COVID-19. 
2. Patients and methods 
2.1. Patients 
During the COVID-19 pandemic, the entirety of patients representing 
flu-like symptoms with an initial diagnosis of the novel coronavirus, 
regardless of demographic values such as age and sex, were included in 
the study. Prior to enrolment, chest high-Resolution CT (HRCT) exam-
ination was obtained from all patients during the acute phase of the 
disease. 
The inclusion criterion was the confirmation of diagnosis of COVID- 
19 through RT-PCR performed on nasopharyngeal swabs samples. Pa-
tients with concurrent pulmonary infections, as confirmed by laboratory 
tests and negative RT-PCR, were excluded. In addition, patients with CT 
imaging suggestive of chronic lung diseases and subsequent pulmonary 
involvement were excluded. Imaging studies were performed between 3 
and 6 days from the onset of flu-like symptoms. We retrospectively 
Fig. 3. An overview of the ten pre-trained networks architecture used in this study. In each network, the convolution layers with the same color are in the same size. 
The straight arrows represent the direction of flow and computation. All convolution layers of the AlexNet, VGG-16 and VGG-19 networks are depicted. However, for 
the other networks, convolution layers of the most repetitive (core) part are depicted. 
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analyzed the HRCT images of patients from September 2019 to 
December 2019 with other causes of atypical and viral pneumonia as 
adenoviral or H1N1 flu from the PACS of our university hospital. 
2.2. Image acquisition 
HRCT images of all subjects were acquired from a 16-MDCT scanner 
(Alexion, Toshiba Medical System, Japan) using the high-resolution 
protocol as follows: patient in the supine position with the arms above 
the head; 1- to 2-mm slice thickness in increments of up to 10 mm from 
the lung apices through the hemidiaphragm, at deep inspiration; tube 
voltage, 120 kVp; tube current–time, 50–100 mAs; pitch, 0.8–1.5, and 
matrix size, 512 � 512 pixel. For further analysis, parenchymal window 
settings were set to a window level and a window width of   600 HU and 
1650 HU, respectively. All CT examinations were performed without the 
use of contrast agent, and images were reconstructed in the transverse 
plane using a high spatial resolution algorithm. 
2.3. CT image pre-processing and analysis 
All CT images of patients were converted to the grey-scale, and then 
reviewed by a radiologist with more than 15 years of experience in 
thoracic imaging. Fig. 1 indicates the CT sample images of patients with 
COVID-19 and other atypical and viral pneumonia diseases. The radi-
ologist defined the rectangular region of infections on CT images. Then, 
the regions were cropped and resized to 60 � 60 pixels (Fig. 2). One 
region of infection was defined per slice for further analysis. The largest 
region was selected if there are more than one regions of infections. 
To evaluate the performance of a radiologist in diagnosing COVID-19 
infection versus other atypical and viral pneumonia diseases (non- 
COVID-19 group), another radiologist who did not define the region of 
infection and was blinded to the results of the laboratory test reviewed 
both patches and CT slices. The performances were reported based on 
visual inspection of patches and slices separately. 
2.4. Deep learning study 
In this study, ten well-known pre-trained CNN were used to 
distinguish infection of COVID-19 from non-COVID-19 group: 1- Alex-
Net, 2- VGG-16, 3- VGG-19, 4- SqueezeNet, 5- GoogleNet, 6- MobileNet- 
V2, 7- ResNet-18, 8- ResNet-50, 9- ResNet-101, and 10- Xception 
(Fig. 3). AlexNet is a type of feedforward CNN with 8-layer deep. It 
contains five convolution layers (conv1 to conv5) and three fully- 
connected layers (fc6 to fc8) [22]. It was proposed by Alex Krizhevsky 
and trained on 1 million images to classify images into 1000 different 
classes (Fig. 3a). VGG-16 is a combination of five convolutional blocks 
(13 convolutional layers) and tree fully-connected layers (fc6 to fc8) 
[23]. It was trained on a million images of 1000 classes (Fig. 3b). 
VGG-19 uses 19 layers, including five convolutional blocks (16 con-
volutional layers) and tree fully-connected layers (fc6-8) [23]. 
Compared to VGG-16, the VGG-19 is a deeper CNN architecture with 
more layers (Fig. 3c). SqueezeNet is a compact CNN with up to 18 
learnable layers deep to classify images into 1000 different classes [24]. 
The network starts with a stand-alone convolution layer followed by 
eight fire modules and ends with a final convolution layer. A scheme of 
one sample module is illustrated in Fig. 3d. The GoogleNet is a deep 
model, which is trained on either the ImageNet or Places365 datasets. In 
this study, we used the GoogleNet trained on the ImageNet dataset [25]. 
The network is 22-layers deep, starts with three convolution layers, 
followed by 9 inception blocks, and ends with a fully-connected layer. 
The inception block as a core part of the GoogleNet is shown in Fig. 3e. 
MobileNet-V2 is a light-weight CNN with 53 layers deep (52 convolution 
and one fully connected layers) [26]. The primary part architecture of 
the network is based on inverted residual and linear bottlenecks. The 
network starts with three convolution layers, followed by 16 inverted 
residual and linear bottleneck blocks and ends with one convolution 
layer and one fully-connected layer. The scheme of the inverted residual 
block, which is the main part of the network and is illustrated in Fig. 3f. 
ResNet is a type of deep network based on residual learning. This kind of 
learning can facilitate the training of networks by considering the layer 
inputs as a reference [27]. All types of ResNet, ResNet-18, ResNet-50, 
and ResNet-101, are versions of ResNet that have their specific residual 
block. ResNet-18 with 22-layers are deep, starts with a convolution layer 
followed by 8 residual blocks and ends with a fully-connected layer. The 
main components of the residual blocks of ResNet-18 are shown in 
Fig. 3g. ResNet-50 is similar to ResNet-18 but has different residual 
blocks scheme and different number (16) of residual blocks that contain 
in the network (Fig. 3h). The ResNet-50 contains 50 layers and same is 
true for ResNet-101. Therefore, it is 101 layers deep with 33 residual 
blocks (Fig. 3i). The last network, Xception, is CNN based on depthwise 
separable convolution layers [28]. It starts with two convolution layers, 
followed by depthwise separable convolution layers, four convolution 
layers, and a fully-connected layer. The main component of depthwise 
separable convolution layers are shown in Fig. 3j. 
We used a transfer-learning to optimize the CNNs to the datasets. In 
this regard, the input layer of the CNNs were replaced with a new one, 
which is consistent with the size of the infection patches (i.e., 60 � 60 �
1). In addition, the dimension of the last fully connected layer of all 
networks was set to the number of the classes, i.e., two (Table 1). All 
networks were trained as follows: optimizer, SGDM; initial learning rate, 
0.01; validation frequency, 5. The dataset was shuffled at every epoch, 
and the training process stopped if the training process did not change 
significantly. For all networks, the dataset was divided into 80% and 
20% for training and validating sets, respectively. The same training and 
validation datasets were selected for all networks to facilitate the per-
formance comparison of networks. 
2.5. Statistical analysis 
The Kolmogorov-Smirnov test was used to check the normality of all 
quantitative data. In addition, the age and sex distributions among 
COVID-19 and non-COVID-19 groups was evaluate by the two-tailed 
independent samples t-test and chi-square test, respectively. A P-value 
smaller than 0.05 was considered as statistically significant. 
Table 1 
Characteristics of ten convolutional neural networks used in this study.  






AlexNet 8 61.0 60-by-60 2-by-1 
VGG-16 16 138 60-by-60 2-by-1 
VGG-19 19 144 60-by-60 2-by-1 
SqueezeNet 18 1.24 60-by-60 2-by-1 
GoogleNet 22 7 60-by-60 2-by-1 
MobileNet- 
V2 
53 3.5 60-by-60 2-by-1 
ResNet-18 18 11.7 60-by-60 2-by-1 
ResNet-50 50 25.6 60-by-60 2-by-1 
ResNet-101 101 44.6 60-by-60 2-by-1 
Xception 71 22.9 60-by-60 2-by-1  
Table 2 
Demographic characteristics data of patients with COVID-19 and other atypical 
and viral pneumonia (Non-COVID-19 group) diseases.  
Characteristics COVID-19 Non-COVID-19 P-value* 
Mean � SD 
Age (year) 50.22 � 10.85 61.45 � 15.04 <0.001 
Gender Number (Percentage) P-value** 
Female 48 (44.44) 35 (40.70) 0.600 
Male 60 (55.56) 51 (59.30) 
p-values were obtained using t-test (*) and chi-square test (**). 
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2.5.1. Performance evaluation of networks 
In order to compare performance of the CNNs and the radiologist, 
five performance indices were calculated as follows: 
Accuracy ¼
NTN þ NTP










Positive ​ Predictive ​ ValueðPPVÞ¼ NTP
NTP þ NFP
(4)  




In this study, the positive and negative cases were assigned to 
COVID-19 and non-COVID-19 infections, respectively. Hence, NTP and 
NTN represent the number of correctly diagnosed COVID-19 and non- 
COVID-19 infections, respectively. NFP and NFN indicate the number of 
incorrectly diagnosed COVID-19 and non-COVID-19 infections, respec-
tively. In addition, the area under the ROC curve (AUC) was calculated 
to indicate the overall performance of the CNNs and the radiologist [29]. 
Statistical analysis was performed the SPSS software (version 24, IBM 
SPSS Statistics 19, IBM Corporation, USA). 
3. Results 
3.1. Demographic characteristics 
In this study, 108 patients with laboratory-proven COVID-19 pneu-
monia (COVID-19 group) including 60 males and 48 females with mean 
age of 50.22 � 10.85 (mean age � SD) were studied. Eighty-six patients 
with atypical pneumonia diseases including 51 male and 35 female with 
mean age of 61.45 � 15.04 were enrolled as controls (nonCOVID-19 
group). No significant differences was seen between COVID-19 and non- 
COVID-19 groups in the term of sex distribution (P > 0.05). However, 
the mean age of COVID-19 group was significantly lower than the non- 
COVID-19 group (P < 0.001, Table 2). 
1020 image patches including 510 COVID-19 and 510 non-COVID- 
19 were extracted from CT slices by a specialist radiologist. The data-
set was divided into 816 (with 50%–50% distribution), and 102 (with 
50%–50% distribution) for training and validating process. 
3.2. Diagnosis of COVID-19 by deep learning and radiologist 
Table 3 indicates the diagnostic performances of ten networks and 
Table 3 
Diagnostic Performance of ten networks and the radiologist in diagnosis of COVID-19 pneumonia 
disease in training and validating datasets. 
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the radiologist in detail with confusion matrices. Networks could 
distinguish COVID-19 from non-COVID-19 groups with AUC in the 
range of 0.894–0.994. The best performance was achieved by ResNet- 
101 and Xception networks. In this regard, ResNet-101 network ach-
ieved AUC of 0.999 (sensitivity, 100%; specificity, 99.26%; accuracy, 
99.63%; PPV, 99.27%; and NPV, 100%) and 0.994 (sensitivity, 100%; 
specificity, 99.02%; accuracy, 99.51%; PPV, 99.03%; and NPV, 100%) 
in training and validating datasets, respectively. Likewise, Xception 
networks could diagnose COVID-19 infection with AUC of 0.997 
(sensitivity, 98.77%; specificity, 100%; accuracy, 99.38%; PPV, 100%; 
and NPV, 98.79%) and 0.994 (sensitivity, 98.04%; specificity, 100%; 
accuracy, 99.02%; PPV, 100%; and NPV, 98.08%) in training and vali-
dating datasets, respectively. 
The radiologist classified COVID-19 and non-COVID-19 groups based 
on CT slices with AUC of 0.873 (sensitivity, 89.21%; specificity, 83.33%; 
accuracy, 86.27%; PPV, 84.25%; and NPV, 88.54%) in validating 
dataset. Moreover based on patches analysis, the radiologist reached a 
lower performance with AUC of 0.603 (sensitivity, 61.76%; specificity, 
58.82%; accuracy, 60.29%; PPV, 60.00%; and NPV, 60.61%). 
Fig. 4a and b represent ROC curves and radar plot of diagnostic 
indices of the radiologist and all networks in validating phase, respec-
tively. The training and validating process of the CNNs are indicated in 
Fig. 5. 
4. Discussion 
In this study, ten well-known CNNs were used to provide a 
comprehensive view of the role of artificial intelligence in diagnosing 
COVID-19 infection. The results showed that deep learning could 
distinguish COVID-19 from other atypical and viral pneumonia diseases 
with high accuracy. The best results were found for the ResNet-101 and 
Xeption networks. Although the Xeption network implied the highest 
performances in classifying COVID-19 and non-COVID-19 infections, it 
did not have the best sensitivity. In contrast, ResNet-101 could diagnose 
COVID-19 infection with the highest sensitivity and implied lower 
specificity compare to the Xeption network. It is desired to introduce a 
method with the highest sensitivity to diagnose all patients with COVID- 
19. In this regard, the ResNet-101 has an advantage over other networks, 
especially Xeption, due to its highest sensitivity and AUC. ResNet-101 is 
trained based on residual learning. This kind of learning can facilitate 
the training of networks by considering the layer inputs as a reference. In 
addition, residual networks are optimized easier, and the accuracy can 
be improved as the depth increases [27]. This specific residual learning 
can lead to better training and provide robust model. Hence, the best 
performance can be obtained using ResNet-101. The radiologist classi-
fied two groups based on CT slices and patches. The results show that the 
Fig. 4a. (a)ROC curves of individual ten networks and the radiologist on 
validating dataset. 
Fig. 4b. (b)Radar plot of individual ten networks and the radiologist on validating dataset.  
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radiologist failed to diagnose COVID-19 based on patches. The main 
reason is that a radiologist needs the whole lung lobe to evaluate the 
intensity of lesions and compare them with the mean density of adjacent 
organs and structures. However, since computerized image analysis can 
recognize the pattern quantitatively with more precision, the CNNs 
could classify two groups with improved performance. The results of the 
present study indicate that the discriminative power of the proposed 
CNN is improved compared with the radiologist (AUC of ResNet-101 vs. 
radiologist: 0.994 vs. 0.873). Also, the deep learning technique can 
accurately aid radiologists to diagnose infections related to COVID-19. 
Only one study was found in the literature which employed deep 
learning for COVID-19 diagnosis [30]. The investigators proposed 
COVNet, which is based on ResNet-50, to diagnose COVID-19, with a 
resulting 90% sensitivity and 96% specificity. They examined and 
modified only one CNN, and in contrast, herein we compared the ten 
most widely used networks to provide comprehensive results, and help 
the other researchers to prevent redundant analysis and select the best 
network for their works. Our results indicate that ResNet-101 has an 
advantage over ResNet-50, the network they used, due to its higher AUC. 
Unlike us, they fed the whole lung region to their network to differen-
tiate CAP form COVID-19 patients. In their approach, some redundant 
data such as interferential vessels can be misdiagnosed as pathology [16, 
31]. Hence, we used ROI based analysis to increase the performance of 
the network. In addition, they differentiated COVID-19 from 
community-acquired pneumonia (CAP) diseases. Differentiating CAP 
from other atypical and viral pneumonia diseases like COVID-19 is not 
Fig. 5. Accuracy (green line) and loss (red line) plot of ten convolutional neural network for training and validating datasets: (a), AlexNet; (b), VGG-16; (c), VGG-19; 
(d), SqueezeNet; (e), GoogleNet; (f), MobileNet-V2; (g), ResNet-18; (h), ResNet-50; (i), ResNet-101; (j), Xception. 
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critical in clinics and CT images. The most critical and important issue 
for radiologists is differentiating COVID-19 and other atypical and viral 
pneumonia diseases, which are the same in CT imagery and have similar 
symptoms [32]. Contrary to their study, we include two groups with 
similar indications, COVID-19, and other atypical and viral pneumonia 
diseases, to obviate this problem and help radiologists in diagnostic 
tasks. Few patients with COVID-19 may have initial negative RT-PCR 
results [33]. Hence, to eliminate any confounding factors, the 
non-COVID-19 patients who referred to the department before the 
COVID-19 outbreak were included to ensure that no patients with 
COVID-19 exist in the non-COVID-19 group. In contrast, they included 
both patients with COVID-19 and CAP during the same period, which 
could introduce bias and affect reliability. 
Moreover, a clinical method with highest sensitivity and earliest 
diagnostic ability is not yet confirmed. Currently, two primary modal-
ities, RT-PCR and CT, are used to diagnose COVID-19. In this regard, 
many studies have utilized CT and RT-PCR to evaluate their diagnostic 
performances; however, the findings must yet be validated. Bernheim 
et al. [34] and Yang et al. [35] reported that RT-PCR diagnosed 
COVID-19 earlier than CT, while in some cases, the CT findings could be 
normal even ten days after symptoms onset. In contrast, Xie et al. [36], 
Ai et al. [37] and Huang et al. [38] found some cases with positive CT 
findings and an initial negative RT-PCR screening result, which later 
became positive upon repeating swab tests. On the other hand, in the 
pandemic phase of COVID-19, requests for CT Exam has substantially 
increased. The increased workload can affect the diagnostic perfor-
mance of radiologists [9,10]. The results of our study indicate that deep 
learning can characterize the pattern of abnormality effectively, and 
may help physicians in managing workflow and diagnosing infection 
related to the COVID-19. 
The limitations of this study are given below. 
First, performance of the proposed CAD system was not compared 
with radiologists. So, future studies should plan to compare the CAD 
system with radiologists. 
Second, few patients with COVID-19 may have negative RT-PCR 
results [39]. Therefore, these patients may have been incorrectly 
excluded from the present study. 
RT-PCR is a current standard method for diagnosing of COVID-19. 
This molecular assay has limitations including time consumption, high 
cost, shortage of the kit, and requires well-equipped laboratories. These 
limitations are overwhelming, especially in middle and low-income 
countries, and may not be effective in reducing the risk of spreading 
the disease. Furthermore, since health systems are often weaker in lower 
and middle income countries, they require technical and financial sup-
port to better manage and diminish the risk of COVID-19 efficiently 
[40]. CT as a first-line imaging modality is fast, widely available, and 
does not waste materials. In this study, we proposed a CAD system based 
on CT images to improve diagnostic performance, which can implement 
in any radiology department and also in deprived areas via telecom-
munication and analyzing the images remotely. Accordingly, the pro-
posed system could reduce radiologist workload burden and could play a 
role as an auxiliary tool with regard to decision-making as to whether an 
infection is COVID-19 related. 
Fig. 5. (continued). 
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5. Conclusion 
In conclusion, a CAD approach based on CT images with promising 
potential was proposed to distinguish infection of COVID-19 from other 
atypical and viral pneumonia diseases. This study showed that the 
ResNet-101 can be considered as a promising model to characterize and 
diagnose COVID-19 infections. This model does not impose substantial 
cost, and can be used as an adjuvant method during CT imaging in 
radiology departments. 
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